ARCHIVES

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

Turmoil in Texas: SEC Issues Subpoena to AVEO on Tivozanib

July 12, 2013

AIDS Patients Face Higher Risk Of HPV-Related Cancers As Immunosuppression Grows

August 28, 2009

DCE Concepts Statements

March 11, 1988

Funding Opportunities (8-page issue).

April 25, 2003

Four Detroit Institutions Merge Cancer Clinical, Research Programs

July 15, 1994

Ultrasound Shown to be Superior Diagnostic Compared to Mammography in Women Ages 30-39

October 26, 2012